BLIS Technologies Limited logo

Blis welcomes new board member

Director Appointment3 August 2018BLTConsumer Staples

Blis Technologies Limited: 81 Glasgow Street, South Dunedin 9012, PO Box 2208, Dunedin 9044, New Zealand
T:+64 3 474 0988 E: info@blis.co.nz W: www.blis.co.nz


NZX Release



3 August 2018



Blis welcomes new board member



Blis Technologies Limited (NZX:BLT) welcomes Mr Barry Richardson as an independent

director of the company following his election at the Annual Meeting held on Friday 27

th

July

2018.


Mr Richardson will bring more than 30 years of management experience in commercialising

science and undertaking business development roles for early stage biotechnology and

nutritional companies, including his time with Tatua Co-Operative Dairy Ltd, Westland Milk

Products Ltd and 10 years as CEO of Blis Technologies Ltd.


Holding a PhD from Massey University and current directorships in CertusBio and CNS

Biotechnology, Mr Richardson will bring valued expertise and experience to the board.


Blis are the developers of the world’s first advanced oral probiotics. The BLIS range includes

products that support ear, nose and throat health. BLIS probiotics were discovered by

Professor John Tagg while working as a researcher at the University of Otago Microbiology

Department.





Tony Offen

Chairman

Contact: 021 463 336

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.